Cargando…
Costello syndrome model mice with a Hras(G12S/+) mutation are susceptible to develop house dust mite-induced atopic dermatitis
Costello syndrome is an autosomal dominant disorder that is caused by germline HRAS mutations. Patients with Costello syndrome present craniofacial abnormalities, cardiac defects, and cancer predisposition, as well as skin abnormalities, including papillomas, keratosis pilaris, and eczematous dermat...
Autores principales: | Katata, Yu, Inoue, Shin-ichi, Asao, Atsuko, Kobayashi, Shuhei, Terui, Hitoshi, Inoue-Shibui, Aya, Abe, Taiki, Niihori, Tetsuya, Aiba, Setsuya, Ishii, Naoto, Kure, Shigeo, Aoki, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426869/ https://www.ncbi.nlm.nih.gov/pubmed/32792500 http://dx.doi.org/10.1038/s41419-020-02845-8 |
Ejemplares similares
-
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer
por: Hartung, Anne-Mette, et al.
Publicado: (2016) -
HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models
por: Dard, Laetitia, et al.
Publicado: (2022) -
Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
por: Nandi, Sayantan, et al.
Publicado: (2022) -
Neonatal Lethal Costello Syndrome and Unusual Dinucleotide Deletion/Insertion Mutations in HRAS Predicting p.Gly12Val
por: Burkitt-Wright, Emma MM, et al.
Publicado: (2012) -
MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model
por: Tidyman, William E., et al.
Publicado: (2021)